Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and susceptibility to diabetic nephropathy in Chinese type 2 diabetic patients: A meta-analysis

Renal Failure

Volumn 35, Issue 7, 2013, Pages 1038-1043

  Chang, Wei Wei ^a   Zhang, Liu ^b   Yao, Ying Shui ^a   Su, Hong ^c   Jin, Yue Long ^a   Chen, Yan ^a  

^a WANNAN MEDICAL COLLEGE   (China)

^b Wuhu Hospital of Traditional Chinese Medicine   (China)

^c ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

C677T polymorphism; Chinese; Diabetes mellitus; Diabetic nephropathy; Meta analysis; Methylenetetrahydrofolate reductase

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2);

ALLELE; CHINESE; DIABETIC NEPHROPATHY; DNA POLYMORPHISM; GENETIC ASSOCIATION; GENETIC MODEL; HUMAN; META ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; REVIEW;

ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; DATA INTERPRETATION, STATISTICAL; DIABETES MELLITUS; DIABETIC NEPHROPATHIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MODELS, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84880295205     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2013.810542     Document Type: Review

References (45)

1. Jawa A, Kcomt J, Fonseca VA. Diabetic nephropathy and retinopathy. Med Clin North Am. 2004;88:1001-1036.
2. Remuzzi G, Schieppati A, Ruggenenti P. Clinical practice. Nephropathy in patients with type 2 diabetes. N Engl J Med. 2002;346:1145-1151.
3. Chowdhury TA, Dyer PH, Kumar S, et al. Genetic determinants of diabetic nephropathy. Clin Sci (Lond). 1999;96(3):221-230.
4. Joss N, Jardine A, Gaffney D, et al. Influence of apolipoprotein E genotype on progression of diabetic nephropathy. Nephron Exp Nephrol. 2005;101(4):e127-e133.
5. Quinn M, Angelico MC, Warram JH, et al. Familial factors determine the development of diabetic nephropathy in patients with IDDM. Diabetologia. 1996;39(8):940-945.
6. Agius E, Attard G, Shakespeare L, et al. Familial factors in diabetic nephropathy: an off-spring study. Diabet Med. 2006;23:331-334.
7. Guldener CV, Stehouwer CDA. Diabetes mellitus and hyperhomocysteinemia. Semin Vasc Med. 2002;2:351-359.
8. Moczulski D, Fojcik H, Zukowska-Szczechowska E, et al. Effects of the C677T and A1298C polymorphisms of the MTHFR gene on the genetic predisposition for diabetic nephropathy. Nephrol Dial Transplant. 2003;18:1535-1540.
9. Minna S, Jukka M, Markku L, et al. Elevated plasma homocysteine level is an independent predictor of coronary heart disease events in patients with type 2 diabetes mellitus. Ann Inter Med. 2004;140: 94-100.
10. Stam F, Guldener CV, Wee PMT, et al. Effect of folic acid on methionine and homocysteine metabolism in end-stage renal disease. Kidney Int. 2000;567:259-264.
11. Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995;10:111-113.
12. Eroglu Z, Erdogan M, Tetik A, et al. The relationship of the methylenetetrahydrofolate reductase C677T gene polymorphism in Turkish type 2 diabetic patients with and without nephropathy. Diab Metab Res Rev. 2007;23:621-624.
13. Shpichinetsky V, Raz I, Friedlander Y, et al. The Association between two common mutations C677T and A1298C in human methylenetetrahydrofolate reductase gene and the risk for diabetic nephropathy in type II diabetic patients. J Nutr. 2000;130: 2493-2497.
14. Zintzaras E, Uhlig K, Koukoulis GN, Papathanasiou AA, Stefanidis I. Methylenetetrahydrofolate reductase gene polymorphism as a risk factor for diabetic nephropathy: a meta-analysis. J Hum Genet. 2007;52(11):881-890.
15. Cui WP, Du B, Jia Y, et al. Is the C677T polymorphism in methylenetetrahydrofolate reductase gene a risk factor for diabetic nephropathy or diabetes mellitus in a Chinese population? Arch Med Res. 2012;43(1):42-50.
16. Cao H, Huang DF, Mao L, et al. Association of homocysteine, methyleneterahydrofolate reductase gene polymorphism with nephropathy in type 2 diabetes mellitus. ACTA Universitatis Medicinalis Nanjing (Natural Science). 2005;25:249-251. (In Chinese).
17. Sun JZ, Xu YC, Zhu YL, et al. An association study of methylenetetrahydrofolate reductase gene polymorphism with diabetic nephropathy. J Nephrol Dial Transplant. 2001;10:33-35. (In Chinese).
18. Sun JZ, Xu YC, Zhu YL, et al. Genetic polymorphism of methylenetetrahydrofolate reductase as a risk factor for diabetic nephropathy in Chinese type 2 diabetic patients. Diabet Res Clin Pract. 2004;64:185-190.
19. Guo QY, Lu JM, Qin HG, et al. Changes of the plasma homocysteine and its mechanism in type 2 diabetes with microangiopathy. Chin J Diabet. 2002;10:32-36. (In Chinese).
20. Qian D. Matched case-control study on the association between AGT and MTHFR gene polymorphism and diabetic nephropathy. Tianjing Medical University Press, Tianjing: 17, 2010. (In Chinese).
21. Mao L. A correlation between 5,10-methylenetetrahydrofolate reductase gene polymorphism, serum homocysteine levels and vascular complications in patients type 2 diabetic mellitus. Nantong Medical College Press, Jiangsu: 27, 2004. (In Chinese).
22. Zintzaras E, Ioannidis JP. Heterogeneity testing in meta-analysis of genome searches. Genet Epidemiol. 2005;28:123-137.
23. Zintzaras E, Lau J. Synthesis of genetic association studies for pertinent gene-disease associations requires appropriate methodological and statistical approaches. J Clin Epidemiol. 2008;61: 634-645.
24. Petitti DB. Meta-analysis, decision analysis, and cost-effectiveness analysis. New York: Oxford University Press; 1994.
25. Trikalinos TA, Salanti G, Zintzaras E, Ioannidis JP. Meta-analysis methods. Adv Genet. 2008;60:311-334.
26. Sun JZ, Xu YC, Zhu YL, et al. The association of methylenetetrahydrofolate reductase gene polymorphism with diabetic nephropathy in type 2 diabetes mellitus in Chinese. Chin J Intern Med. 2001;40:529-532. (In Chinese).
27. Lin R, Wang CN, Liu XM. Matched case-control study on the association between polymorphism of methylenetetrahydrofolate reductase (MTHFR) gene and diabetic nephropathy in type 2 diabetic patients. Modern Prevent Med. 2009;36:3801-3804. (In Chinese).
28. Yue H, Liu J, Kang WJ, et al. Relationship between plasma level of homocysteine and urine microalbumin in incipient type 2 diabetic nephropathy. Chin J Gen Pract. 2006;15:725-729. (In Chinese).
29. Chen AR, Ning YY, Zhu XZ, et al. Study on the relationship between gene polymorphisms of N5,10-methylenetetrahydrofolate reductase and nephropathy in type 2 diabetes mellitus in Gansu Han Chinese of China. Clin J Prev Contr Chron Non-Commun Dis. 2004;12:195-197. (In Chinese).
30. Xu JS, Zhang J, Shan BE, et al. Relationship between methylenetetrahydrofolate reductase gene polymorphism and diabetic nephropathy in type 2 diabetes mellitus in the Hans of Hebei Province. Clin Focus. 2003;18:787-789. (In Chinese).
31. Wang LQ, Wang JY, Xue YM, et al. Relationship between methylenetetrahydrofolate reductase gene polymorphism and diabetic nephropathy. Chin J Med Genet. 2001;18:226-228. (In Chinese).
32. Yang GQ, Lu JM, Pan CY. Study on the relationship between N5, 10-methylenetetrahydrofolate reductase gene polymorphism and the susceptibility to microangiopathy in type 2 diabetes mellitus. Chin J Endocrinol Metab. 2001;17:224-227. (In Chinese).
33. Zhang YD, Shi L, Yu M, et al. Correlation between single nucleotide polymorphisms in methylenetetrahydrofolate reductase gene and type 2 diabetes mellitus in Chinese Han nationality. J Mod Lab Med. 2010;25:14-16. (In Chinese).
34. Wen J, Chen ZQ, Li XM, et al. Correlation of MTHFR gene polymorphism and plasma homocysteine with microalbuminuria in type 2 diabetes. Shanghai Med J. 2008;31:47-51. (In Chinese).
35. Chen P, Pan YH, Sun DL, et al. The association between polymorphism of methylenetetrahydrofolate reductase (MTHFR) gene and type 2 diabetes mellitus. J Qiqihar Med Coll. 2008;29: 672-673. (In Chinese).
36. Mooyaart AL, Valk EJJ, van Es LA, et al. Genetic associations in diabetic nephropathy: a meta-analysis, Diabetologia. 2011;54: 544-553.
37. Boushey CJ, Beresford SAA, Omenn GS. Motulsky AGA quantitative assessment of plasma homocysteine as a risk factor for vascular disease. JAMA. 1995;274:1049-1057.
38. Fletcher O. Kessling AM MTHFR association with arteriosclerotic vascular disease? Hum Genet. 1998;103:11-21.
39. Mtiraoui N, Ezzidi I, Chaieb M, et al. MTHFR C677T and A1298C gene polymorphisms an hyperhomocysteinemia as risk factors of diabetic nephropathy in type 2 diabetes patients. Diabetes Res Clin Pract. 2007;75:99-106.
40. Maeda M, Yamamoto I, Fujio Y, et al. Homocysteine induces vascular endothelial growth factor expression in differentiated THP-1 macrophages. Biochim Biophys Acta. 2003;1623: 41-46.
41. Roybal CN, Yang S, Sun CW, et al. Homocysteine increases the expression of vascular endothelial growth factor by a mechanism involving endoplasmic reticulum stress and transcription factor ATF4. J Biol Chem. 2004;279:14844-14852.
42. Sung SH, Ziyadeh FN, Wang A, et al. Blockade of vascular endothelial growth factor signaling ameliorates diabetic albuminuria in mice. J Am Soc Nephrol. 2006;117:3093-3104.
43. Shcherbak NS, Shutskaya ZV, Sheidina AM, et al. Methylenetetrahydrofolate reductase gene polymorphism as a risk factor for diabetic nephropathy in IDDM patients. Mol Genet Metab. 1999;68(3):375-378.
44. Neugebauer S, Baba T, Watanabe T. Methylenetetrahydrofolate reductase gene polymorphism as a risk factor for diabetic nephropathy in NIDDM patients. Lancet. 1998;352:454-457.
45. Scaglione L, Ganbino R, Gay M, et al. Methylenetetrahydrofolate reductase gene polymorphism is not associated to diabetic nephropathy in type 2 diabetes. Diabetologia. 1999;42:A329.